These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25136887)

  • 1. Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement.
    van Nunen LX; Lenders GD; Schampaert S; van 't Veer M; Wijnbergen I; Brueren GR; Tonino PA; Pijls NH
    EuroIntervention; 2015 Dec; 11(8):905-13. PubMed ID: 25136887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of regadenoson for measurement of fractional flow reserve.
    Prasad A; Zareh M; Doherty R; Gopal A; Vora H; Somma K; Mehra A; Clavijo LC; Matthews RV; Shavelle DM
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):369-74. PubMed ID: 23765847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of regadenoson and nitroprusside to adenosine for measurement of fractional flow reserve: A systematic review and meta-analysis.
    Lee JZ; Singh N; Nyotowidjojo I; Howe C; Low SW; Nguyen T; Pinto D; Kumar G; Lee KS
    Cardiovasc Revasc Med; 2018 Mar; 19(2):168-174. PubMed ID: 28888873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory.
    Stolker JM; Lim MJ; Shavelle DM; Morris DL; Angiolillo DJ; Guzman LA; Kennedy KF; Weber E; Zareh M; Neumayr RH; Zenni MM
    Cardiovasc Revasc Med; 2015; 16(5):266-71. PubMed ID: 26242981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of hyperemic efficacy between central and peripheral venous adenosine infusion for fractional flow reserve measurement.
    Seo MK; Koo BK; Kim JH; Shin DH; Yang HM; Park KW; Lee HY; Kang HJ; Kim HS; Oh BH; Park YB
    Circ Cardiovasc Interv; 2012 Jun; 5(3):401-5. PubMed ID: 22647519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve.
    Arumugham P; Figueredo VM; Patel PB; Morris DL
    EuroIntervention; 2013 Feb; 8(10):1166-71. PubMed ID: 23164748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous regadenoson with aminophylline reversal is safe and equivalent to intravenous adenosine infusion for fractional flow reserve measurements.
    Edward JA; Lee JH; White CJ; Morin DP; Bober R
    Clin Cardiol; 2018 Oct; 41(10):1348-1352. PubMed ID: 30125368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of regadenoson for assessing fractional flow reserve.
    Nair PK; Marroquin OC; Mulukutla SR; Khandhar S; Gulati V; Schindler JT; Lee JS
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1085-92. PubMed ID: 22017933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive myocardial hyperaemia for functional assessment of coronary stenosis severity.
    Stoller M; Seiler C
    EuroIntervention; 2017 Jun; 13(2):e201-e209. PubMed ID: 27993753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of fractional flow reserve according to the methods of hyperemia induction.
    Lim WH; Koo BK; Nam CW; Doh JH; Park JJ; Yang HM; Park KW; Kim HS; Takashima H; Waseda K; Amano T; Kato D; Kurita A; Oi M; Toyofuku M; van Nunen L; Pijls NH
    Catheter Cardiovasc Interv; 2015 May; 85(6):970-6. PubMed ID: 25413590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study.
    Leone AM; Porto I; De Caterina AR; Basile E; Aurelio A; Gardi A; Russo D; Laezza D; Niccoli G; Burzotta F; Trani C; Mazzari MA; Mongiardo R; Rebuzzi AG; Crea F
    JACC Cardiovasc Interv; 2012 Apr; 5(4):402-8. PubMed ID: 22516396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fractional flow reserve measurements using intracoronary adenosine versus intracoronary sodium nitroprusside infusions in moderately stenotic coronary artery lesions.
    Safi M; Namazi MH; Fooladi E; Vakili H; Parsa SA; Khaheshi I; Abbasi MA; Movahed MR
    Cardiovasc Revasc Med; 2016; 17(7):441-443. PubMed ID: 27432209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional flow reserve and minimum Pd/Pa ratio during intravenous adenosine infusion: very similar but not always the same.
    Echavarria-Pinto M; Petraco R; van de Hoef TP; Gonzalo N; Nijjer S; Tarkin JM; Ibanez B; Sen S; Jimenez-Quevedo P; Nunez-Gil IJ; Nombela-Franco L; Alfonso F; Fernandez-Ortiz A; Macaya C; Piek JJ; Davies J; Escaned J
    EuroIntervention; 2016 Jan; 11(9):1013-9. PubMed ID: 25366652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of standard- and high-dose intracoronary adenosine for the measurement of coronary fractional flow reserve (FFR).
    Röther J; Achenbach S; Tröbs M; Blachutzik F; Nef H; Marwan M; Schlundt C
    Clin Res Cardiol; 2016 Dec; 105(12):1003-1010. PubMed ID: 27307094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study.
    Leone AM; Scalone G; De Maria GL; Tagliaferro F; Gardi A; Clemente F; Basile E; Cialdella P; De Caterina AR; Porto I; Aurigemma C; Burzotta F; Niccoli G; Trani C; Rebuzzi AG; Crea F
    EuroIntervention; 2015 Aug; 11(4):421-7. PubMed ID: 25007836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study.
    DiBella EV; Fluckiger JU; Chen L; Kim TH; Pack NA; Matthews B; Adluru G; Priester T; Kuppahally S; Jiji R; McGann C; Litwin SE
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1435-44. PubMed ID: 21968545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve.
    Rudzinski W; Waller AH; Rusovici A; Dehnee A; Nasur A; Benz M; Sanchez S; Klapholz M; Kaluski E
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):540-4. PubMed ID: 22961876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory.
    Jang HJ; Koo BK; Lee HS; Park JB; Kim JH; Seo MK; Yang HM; Park KW; Nam CW; Doh JH; Kim HS
    Eur Heart J; 2013 Jul; 34(27):2055-62. PubMed ID: 23396491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous nicorandil versus adenosine for fractional flow reserve measurement: a crossover, randomized study.
    Nishi T; Kitahara H; Fujimoto Y; Nakayama T; Nagashima K; Hanaoka H; Kobayashi Y
    Heart Vessels; 2018 Dec; 33(12):1570-1575. PubMed ID: 29858919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.